Mind Medicine

Bruce Linton-backed psychedelics business Mind Medicine joins NEO ...

MMED Profile

  • Sector: Health Technology
  • Industry: Biotechnology

Mind Medicine (MindMed), Inc. operates as a neuro-pharmaceutical company that discovers, develops and deploys psychedelic medicines to improve health, promote wellness and alleviate suffering. The firm develops a non-hallucinogenic version of the psychedelic ibogaine. The company was founded by Stephen L. Hurst, Stanley D. Glick, and Jamon Alexander Rahn in 2019 and is headquarter in Toronto, Canada.

Why Kevin O’Leary is betting on psychedelics
Kevin O’Leary is backing a neuro-pharmaceutical company testing psychedelic-inspired medicines.

[bbp-topic-index] [bbp-topic-form]

Recent News

All posts made on this website are provided for information purposes only. None of the information here is intended as investment advice, as an offer or solicitation of an offer to buy or sell, or as a recommendation, endorsement, or sponsorship of any security, Company, or fund. Before making an investment decision, you should seek the advice of a qualified and registered securities professional. Candlr is not receiving payment or commissions from companies for shared content on Candlr website unless its specified. View full disclaimer HERE.